HYPERPHOSPHATEMIA
Clinical trials for HYPERPHOSPHATEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERPHOSPHATEMIA trials appear
Sign up with your email to follow new studies for HYPERPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AP301 aims to tame dangerous phosphate levels in dialysis patients
Disease control Recruiting nowThis phase 3 trial tests whether AP301 can safely lower high blood phosphate levels in people with end-stage kidney disease who are on dialysis. About 264 participants will receive either AP301 or a low-dose comparator for 8 weeks, then all receive AP301 for 24 weeks. The study m…
Matched conditions: HYPERPHOSPHATEMIA
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Massive study aims to find safe drug doses for kids
Knowledge-focused Recruiting nowThis study looks at how certain medicines act in the bodies of children and young adults under 21. Researchers want to find the safest and most effective doses for these age groups. Participants are already taking these drugs as part of their regular care, or have had a recent CO…
Matched conditions: HYPERPHOSPHATEMIA
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC